Marathon Flow Directed Micro Catheter, Model #105-5055. Product Usage: The Marathon Flow Directed Micro Catheter is intended to access the peripheral and neuro vasculature for the controlled selective infusion of physician-specified therapeutic agents such as embolization materials and of diagnostic materials such as contrast media.
Publicado el 3 de octubre de 2012 · Inicio del retiro: 23 de septiembre de 2011
Resumen
FDA registra el retiro Z-2472-2012 de dispositivos médicos de Clase II, publicado el 3 de octubre de 2012 e iniciado el 23 de septiembre de 2011. Empresa responsable: Micro Therapeutics Inc, Dba Ev3 Neurovascular; Estado: Finalizado; Cantidad reportada: 23 units total; Lote: Lot # 9374210. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
The recall was initiated because ev3 Neurovascular has identified one lot of UltraFlow Flow Directed Micro Catheters and Marathon Flow Directed Micro Catheters may have been mislabeled.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Micro Therapeutics Inc, Dba Ev3 Neurovascular
- Distribuidor
- Worldwide Distribution - US Nationwide including the states: MN, FL, OR, TX and the countries of: Brazil, Belgium, Czech Republic, Finlind, France, Germany, Netherlands, Poland, and United Kingdom.
- Lote
- Lot # 9374210
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAev3 Pipeline Flex Embolization Device. For neurological endovascular use.1 de abril de 2020
- FDAAlligator Retrieval Device (ARD). Used in the peripheral and neurovasculature for foreign body removal.23 de abril de 2014
- FDAPipeline Embolization Device (PED). Used endovascular treatment of adults with intracranial aneurysms in the23 de abril de 2014
- FDAPipeline Embolization Device (PED) The Pipeline Embolization Device is indicated for the endovascular4 de septiembre de 2013
- FDAbuPROPion Hydrochloride Extended-Release Tablets (XL), 150 mg, UD 100 Tablets (10 x 10) per carton, Rx only,10 de octubre de 2012
- FDAUltraFlow HPC Flow Directed Micro Catheter, Model # 105-5065. Product Usage: The UltraFlow HPC Flow Directed3 de octubre de 2012
Preguntas sobre este retiro
¿Marathon Flow Directed Micro Catheter, Model #105-5055. Product Usage: The Marathon Flow Directed Micro Catheter is intended to access the peripheral and neuro vasculature for the controlled selective infusion of physician-specified therapeutic agents such as embolization materials and of diagnostic materials such as contrast media. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2472-2012 el 3 de octubre de 2012. Peligro reportado: The recall was initiated because ev3 Neurovascular has identified one lot of UltraFlow Flow Directed Micro Catheters and Marathon Flow Directed Micro Catheters may have been mislabeled.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter